Copyright © 2012 Vajihe Izadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. Y. F. Tian, C. H. Chu, M. H. Wu et al., “Anthropometric measures, plasma adiponectin, and breast cancer risk,” Endocrine-Related Cancer, vol. 14, no. 3, pp. 669–677, 2007. View at Publisher · View at Google Scholar · View at Scopus
2. J. H. Kang, B. Y. Yu, and D. S. Youn, “Relationship of serum adiponectin and resistin levels with breast cancer risk,” Journal of Korean Medical Science, vol. 22, no. 1, pp. 117–121, 2007. View at Scopus
3. A. Esmaillzadeh and L. Azadbakht, “Major dietary patterns in relation to general obesity and central adiposity among Iranian women,” Journal of Nutrition, vol. 138, no. 2, pp. 358–363, 2008. View at Scopus
4. K. F. Hilpert, P. M. Kris-Etherton, and S. G. West, “Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults,” Journal of Nutrition, vol. 135, no. 5, pp. 1075–1079, 2005. View at Scopus
5. F. Hosseinpanah, M. Barzin, P. S. Eskandary, P. Mirmiran, and F. Azizi, “Trends of obesity and abdominal obesity in Tehranian adults: a cohort study,” BMC Public Health, vol. 9, article 426, 2009. View at Publisher · View at Google Scholar · View at Scopus
6. A. Esmaillzadeh, H. Khosravi Boroujeni, and L. Azadbakht, “Consumption of energy-dense diets in relation to cardiometabolic abnormalities among Iranian women,” Public Health Nutrition, vol. 19, pp. 1–8, 2011.
7. A. Esmaillzadeh and L. Azadbakht, “Dietary energy density and the metabolic syndrome among Iranian women,” European Journal of Clinical Nutrition, vol. 65, no. 5, pp. 598–605, 2011. View at Publisher · View at Google Scholar · View at Scopus
8. A. Esmaillzadeh, M. Kimiagar, Y. Mehrabi, L. Azadbakht, F. B. Hu, and W. C. Willett, “Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women,” American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 910–918, 2007. View at Scopus
9. A. Esmaillzadeh, M. Kimiagar, Y. Mehrabi, L. Azadbakht, F. B. Hu, and W. C. Willett, “Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome,” American Journal of Clinical Nutrition, vol. 84, no. 6, pp. 1489–1497, 2006. View at Scopus
10. A. Esmaillzadeh and L. Azadbakht, “Legume consumption is inversely associated with serum concentrations of adhesion molecules and inflammatory biomarkers among Iranian women,” Journal of Nutrition, vol. 142, pp. 334–339, 2012.
11. L. Azadbakht and A. Esmaillzadeh, “Red meat intake is associated with metabolic syndrome and the plasma c-reactive protein concentration in women,” Journal of Nutrition, vol. 139, no. 2, pp. 335–339, 2009. View at Publisher · View at Google Scholar · View at Scopus
12. L. Azadbakht, P. J. Surkan, A. Esmaillzadeh, and W. C. Willett, “The dietary approaches to stop hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients,” Journal of Nutrition, vol. 141, no. 6, pp. 1083–1088, 2011. View at Publisher · View at Google Scholar · View at Scopus
13. E. E. Calle and R. Kaaks, “Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms,” Nature Reviews Cancer, vol. 4, no. 8, pp. 579–591, 2004. View at Scopus
14. L. Otvos Jr., E. Haspinger, F. L. Russa, et al., “Design and development of a peptide-based adiponectin receptor agonist for cancer treatment,” BMC Biotechnology, vol. 11, article 90, 2011.
15. I. Kelesidis, T. Kelesidis, and C. S. Mantzoros, “Adiponectin and cancer: a systematic review,” British Journal of Cancer, vol. 94, no. 9, pp. 1221–1225, 2006. View at Publisher · View at Google Scholar · View at Scopus
16. M. E. Grossmann, K. J. Nkhata, N. K. Mizuno, A. Ray, and M. P. Cleary, “Effects of adiponectin on breast cancer cell growth and signaling,” British Journal of Cancer, vol. 98, no. 2, pp. 370–379, 2008. View at Publisher · View at Google Scholar · View at Scopus
17. T. Jardé, F. Caldefie-Chézet, N. Goncalves-Mendes et al., “Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies,” Endocrine-Related Cancer, vol. 16, no. 4, pp. 1197–1210, 2009. View at Publisher · View at Google Scholar · View at Scopus
18. D. Barb, C. J. Williams, A. K. Neuwirth, and C. S. Mantzoros, “Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence,” American Journal of Clinical Nutrition, vol. 86, no. 3, pp. S858–S866, 2007. View at Scopus
19. S. Shahar, R. M. Salleh, A. R. Ghazali, P. B. Koon, and W. N. Wan Mohamud, “Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley,” Asian Pacific Journal of Cancer Prevention, vol. 11, no. 1, pp. 61–66, 2010. View at Scopus
20. Y. Miyoshi, T. Funahashi, S. Kihara et al., “Association of serum adiponectin levels with breast cancer risk,” Clinical Cancer Research, vol. 9, no. 15, pp. 5699–5704, 2003. View at Scopus
21. Y. M. Liu, J. M. Lacorte, N. Viguerie et al., “Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5881–5886, 2003. View at Publisher · View at Google Scholar · View at Scopus
22. M. Cnop, P. J. Havel, K. M. Utzschneider et al., “Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex,” Diabetologia, vol. 46, no. 4, pp. 459–469, 2003. View at Scopus
23. A. Xu, K. W. Chan, R. L. C. Hoo et al., “Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes,” Journal of Biological Chemistry, vol. 280, no. 18, pp. 18073–18080, 2005. View at Publisher · View at Google Scholar · View at Scopus
24. N. Bansal, V. Charlton-Menys, P. Pemberton et al., “Adiponectin in umbilical cord blood is inversely related to low-density lipoprotein cholesterol but not ethnicity,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2244–2249, 2006. View at Publisher · View at Google Scholar · View at Scopus
25. V. G. Kaklamani, M. Sadim, A. Hsi et al., “Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk,” Cancer Research, vol. 68, no. 9, pp. 3178–3184, 2008. View at Publisher · View at Google Scholar · View at Scopus
26. A. Körner, K. Pazaitou-Panayiotou, T. Kelesidis et al., “Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 1041–1048, 2007. View at Publisher · View at Google Scholar · View at Scopus
27. C. Mantzoros, E. Petridou, N. Dessypris et al., “Adiponectin and breast cancer risk,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1102–1107, 2004. View at Publisher · View at Google Scholar · View at Scopus
28. K. Michalakis, C. J. Williams, N. Mitsiades et al., “Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 2, pp. 308–313, 2007. View at Publisher · View at Google Scholar · View at Scopus
29. A. E. Cust, R. Kaaks, C. Friedenreich et al., “Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 1, pp. 255–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
30. S. Otake, H. Takeda, S. Fujishima et al., “Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer,” World Journal of Gastroenterology, vol. 16, no. 10, pp. 1252–1257, 2010. View at Publisher · View at Google Scholar · View at Scopus
31. S. S. Tworoger, A. H. Eliassen, T. Kelesidis et al., “Plasma adiponectin concentrations and risk of incident breast cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1510–1516, 2007. View at Publisher · View at Google Scholar · View at Scopus
32. O. Treeck, C. Lattrich, I. Juhasz-Boess, S. Buchholz, G. Pfeiler, and O. Ortmann, “Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells,” British Journal of Cancer, vol. 99, no. 8, pp. 1246–1250, 2008. View at Publisher · View at Google Scholar · View at Scopus
33. L. Dal Maso, L. S. A. Augustin, A. Karalis et al., “Circulating adiponectin and endometrial cancer risk,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 3, pp. 1160–1163, 2004. View at Publisher · View at Google Scholar · View at Scopus
34. P. T. Soliman, D. Wu, G. Tortolero-Luna et al., “Association between adiponectin, insulin resistance, and endometrial cancer,” Cancer, vol. 106, no. 11, pp. 2376–2381, 2006. View at Publisher · View at Google Scholar · View at Scopus
35. E. Petridou, C. Mantzoros, N. Dessypris et al., “Clinical case seminar - Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 3, pp. 993–997, 2003. View at Publisher · View at Google Scholar · View at Scopus
36. B. He, Y. Pan, Y. Zhang et al., “Effects of genetic variations in the Adiponectin pathway genes on the risk of colorectal cancer in the Chinese population,” BMC Medical Genetics, vol. 12, article 94, 2011. View at Publisher · View at Google Scholar · View at Scopus
37. J. L. Beebe-Dimmer, K. A. Zuhlke, A. M. Ray, E. M. Lange, and K. A. Cooney, “Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 4, pp. 362–368, 2010. View at Publisher · View at Google Scholar · View at Scopus
38. A. Yıldırım, M. Bilici, K. Çayir, V. Yanmaz, S. Yildirim, and S. B. Tekin, “Serum adiponectin levels in patients with esophageal cancer,” Japanese Journal of Clinical Oncology, vol. 39, no. 2, pp. 92–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
39. S. Goktas, M. I. Yilmaz, K. Caglar, A. Sonmez, S. Kilic, and S. Bedir, “Prostate cancer and adiponectin,” Urology, vol. 65, no. 6, pp. 1168–1172, 2005. View at Publisher · View at Google Scholar · View at Scopus
40. V. G. Kaklamani, K. B. Wisinski, M. Sadim et al., “Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk,” Journal of the American Medical Association, vol. 300, no. 13, pp. 1523–1531, 2008. View at Publisher · View at Google Scholar · View at Scopus
41. R. Z. Stolzenberg-Solomon, S. Weinstein, M. Pollak et al., “Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers,” American Journal of Epidemiology, vol. 168, no. 9, pp. 1047–1055, 2008. View at Publisher · View at Google Scholar · View at Scopus
42. J. M. Schenk, A. R. Kristal, M. L. Neuhouser et al., “Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial,” Prostate, vol. 69, no. 12, pp. 1303–1311, 2009. View at Publisher · View at Google Scholar · View at Scopus
43. H. Li, M. J. Stampfer, L. Mucci et al., “A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival,” Clinical Chemistry, vol. 56, no. 1, pp. 34–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
44. D. Housa, Z. Vernerova, J. Heracek, et al., “Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer,” Physiological Research, vol. 57, pp. 451–458, 2008.
45. J. D. Bub, T. Miyazaki, and Y. Iwamoto, “Adiponectin as a growth inhibitor in prostate cancer cells,” Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1158–1166, 2006. View at Publisher · View at Google Scholar · View at Scopus
46. C. M. L. Fontana, M. E. M. Artola, N. D. M. Monaco, et al., “Influence of leptin and adiponectin on prostate cancer,” Archivos Españoles de Urología, vol. 62, pp. 103–108, 2009.
47. E. K. Wei, E. Giovannucci, C. S. Fuchs, W. C. Willett, and C. S. Mantzoros, “Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study,” Journal of the National Cancer Institute, vol. 97, no. 22, pp. 1688–1694, 2005. View at Publisher · View at Google Scholar · View at Scopus
48. A. Lukanova, S. Söderberg, R. Kaaks, E. Jellum, and P. Stattin, “Serum adiponectin is not associated with risk of colorectal cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 2, pp. 401–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
49. I. Wolf, S. Sadetzki, H. Kanely et al., “Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients,” Cancer, vol. 106, no. 4, pp. 966–973, 2006. View at Publisher · View at Google Scholar · View at Scopus
50. L. Liu, R. Zhong, S. Wei, et al., “Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer,” PLoS ONE, vol. 6, Article ID e27301, 2011.
51. L. G. Carvajal-Carmona, S. Spain, D. Kerr, R. Houlston, J. B. Cazier, and I. Tomlinson, “Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK,” Human Molecular Genetics, vol. 18, no. 10, pp. 1889–1892, 2009. View at Publisher · View at Google Scholar · View at Scopus
52. M. Dalamaga, I. Migdalis, J. L. Fargnoli et al., “Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study,” Cancer Causes and Control, vol. 20, no. 5, pp. 625–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
53. M. C. Chang, Y. T. Chang, T. C. Su et al., “Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis,” Pancreas, vol. 35, no. 1, pp. 16–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
54. C. Weyer, T. Funahashi, S. Tanaka et al., “Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 1930–1935, 2001. View at Publisher · View at Google Scholar · View at Scopus
55. R. E. Bachelder, M. A. Wendt, and A. M. Mercurio, “Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4,” Cancer Research, vol. 62, no. 24, pp. 7203–7206, 2002. View at Scopus
56. E. Mueller, P. Sarraf, P. Tontonoz et al., “Terminal differentiation of human breast cancer through PPARγ,” Molecular Cell, vol. 1, no. 3, pp. 465–470, 1998. View at Scopus
57. Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L. J. Mandarino, and R. A. DeFronzo, “Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4312–4319, 2004. View at Publisher · View at Google Scholar · View at Scopus
58. F. Jaleel, A. Jaleel, J. Aftab, and M. A. Rahman, “Relationship between adiponectin, glycemic control and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease,” Clinica Chimica Acta, vol. 370, no. 1-2, pp. 76–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
59. S. E. Hankinson, W. C. Willett, J. E. Manson et al., “Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women,” Journal of the National Cancer Institute, vol. 87, no. 17, pp. 1297–1302, 1995. View at Scopus
60. M. N. Dieudonne, M. Bussiere, E. Dos Santos, M. C. Leneveu, Y. Giudicelli, and R. Pecquery, “Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 271–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
61. D. Barb, A. Neuwirth, C. S. Mantzoros, and S. P. Balk, “Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway,” Endocrine-Related Cancer, vol. 14, no. 4, pp. 995–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
62. Y. J. Jeong, J. G. Bong, S. H. Park, J. H. Choi, and H. K. Oh, “Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer,” Journal of Breast Cancer, vol. 14, no. 2, pp. 96–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
63. X. Xiang, A. K. Saha, R. Wen, N. B. Ruderman, and Z. Luo, “AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms,” Biochemical and Biophysical Research Communications, vol. 321, no. 1, pp. 161–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
64. N. Yamaguchi, J. G. M. Argueta, Y. Masuhiro et al., “Adiponectin inhibits Toll-like receptor family-induced signaling,” FEBS Letters, vol. 579, no. 30, pp. 6821–6826, 2005. View at Publisher · View at Google Scholar · View at Scopus
65. T. Fujisawa, H. Endo, A. Tomimoto et al., “Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition,” Gut, vol. 57, no. 11, pp. 1531–1538, 2008. View at Publisher · View at Google Scholar · View at Scopus
66. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at Scopus
67. R. Tsukinoki, K. Morimoto, and K. Nakayama, “Association between lifestyle factors and plasma adiponectin levels in Japanese men,” Lipids in Health and Disease, vol. 4, article 27, 2005. View at Publisher · View at Google Scholar · View at Scopus
68. J. L. Fargnoli, T. T. Fung, D. M. Olenczuk, J. P. Chamberland, F. B. Hu, and C. S. Mantzoros, “Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study,” American Journal of Clinical Nutrition, vol. 88, no. 5, pp. 1213–1224, 2008. View at Publisher · View at Google Scholar · View at Scopus
69. Y. Nakamura, H. Ueshima, N. Okuda et al., “Relation of dietary and other lifestyle traits to difference in serum adiponectin concentration of Japanese in Japan and Hawaii: the INTERLIPID Study,” American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 424–430, 2008. View at Scopus
70. C. S. Mantzoros, C. J. Williams, J. E. Manson, J. B. Meigs, and F. B. Hu, “Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women,” American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 328–335, 2006. View at Scopus
71. M. H. Rokling-Andersen, J. E. Reseland, M. B. Veierød et al., “Effects of long-term exercise and diet intervention on plasma adipokine concentrations,” American Journal of Clinical Nutrition, vol. 86, no. 5, pp. 1293–1301, 2007. View at Scopus
72. Z. Kovacova, M. Vitkova, M. Kovacikova et al., “Secretion of adiponectin multimeric complexes from adipose tissue explants is not modified by very low calorie diet,” European Journal of Endocrinology, vol. 160, no. 4, pp. 585–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
73. K. Shinmura, K. Tamaki, K. Saito, Y. Nakano, T. Tobe, and R. Bolli, “Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase,” Circulation, vol. 116, no. 24, pp. 2809–2817, 2007. View at Publisher · View at Google Scholar · View at Scopus